Heres what early studies have shown: Pancreatitis: Reported in about 0.4% Gallbladder problems: Seen in about 1.1% , with no cases in the placebo group Heart rhythm changes: Reported more often with retatrutide ( about 6% vs 3% with placebo ) Liver enzyme increases: Rare (around 1% ), with overall liver health markers staying stable While these serious side effects were uncommon, theyre still important to keep in mind
The lever they offer in return is a 30% off first month promo (code Shed10, auto-applied through this link) which softens the unknown
You can access a special print version by clicking the "Print" icon in the upper right corner of this report
Trish Reynolds, MBBS, FRACP, from Edanz ( for editing a draft of this manuscript
External resources In case I do not see you, good afternoon, good evening, and good night